- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Beth Wittmer Outlines Changes to Care Management During a Shift Toward Value-Based Care
Taking care of a patient in the shift to value-based care means utilizing care managers to answer questions when the physician isn’t available, says Beth Wittmer, RN, OCN, manager of care management at Florida Cancer Specialists and Research Institute.
Taking care of a patient in the shift to value-based care means utilizing care managers to answer questions when the physician isn’t available, says Beth Wittmer, RN, OCN, manager of care management at Florida Cancer Specialists and Research Institute.
Transcript
How has care management evolved in cancer care during the shift to value-based care?
We built this program for our company 3 years ago and the whole idea is that we were going to take care of the patient, all-encompassing. So instead of from doctor visit to doctor visit and occasionally the patient may call to the clinic—that call may not get answered until late in the afternoon. We’re eliminating those issues because we have care managers who are working remotely out of the clinic settings, and they’re there to answer those questions. Currently we have over a thousand phone calls going out and coming in every day just to our care management department, as well as a triage nurse that works with care management to field anybody that may not have a care manager. They’re helping assist with clinical issues.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
